July Scans: Continued Stability and Liver Response

On Monday, July 13, I had my latest round of follow-up scans. This set of scans comes five months after my previous update in February, and I am pleased to share that the results show continued stability across the board.

Here is the breakdown of the findings from the radiology report:

1. Continued Liver Metastasis Shrinkage

The metastasis in hepatic segment III, which was treated with SBRT in November 2025, shows a continued decrease in size. This indicates that the targeted radiation treatment continues to be effective in controlling and reducing this specific lesion.

Liver Lesion Shrunk!

2. Stability in Existing Pelvic and Perinephric Masses

The right pelvic/sacral mass (the original metastatic tumor from 2019, treated with proton radiation in early 2023) remains stable and unchanged.

Pelvic/Sacral Mass Stable

The right perinephric mass (the lesion near my right kidney, treated with proton SBRT in early 2025) also remains stable and unchanged.

Right Perinephric Mass Stable

3. No New Disease Progression

There is no evidence of disease progression anywhere in the abdomen or pelvis.

There is no evidence of disease progression in the chest.

Current Status

We are now seven and a half years out from my January 2019 metastatic recurrence. Given the high-grade nature of this myxoid liposarcoma, achieving continued stability across multiple treated areas without any new lesions or chest progression is the best outcome we can hope for on these scan days.

Because everything is holding steady, there are no changes to my current treatment plan. I am still receiving chemotherapy (Doxil) every 6 weeks, which remains my current regimen. We will continue on this path and schedule the next round of routine surveillance scans, likely in about 4 months.

Thank you, as always, for following along and for your continued support.

--Dave

Seven Years — And Once Again “Stable”

January 15, 2026 marked seven years since my re-diagnosis.

That recurrence came during what was supposed to be my 10-year NED milestone. Instead, doctors found a large metastatic tumor in my right pelvis and sacrum. A semi-hemipelvectomy (amputation of my right leg and hip) was recommended as the most aggressive option for local control.  I said no.

Seven years later, I’m still here, still ambulatory, still fighting — and I got to keep my leg. It’s hard to ask for much more than that. And yesterday, I scored another victory…

Latest Scans

Yesterday (February 23), I had my first scans since completing SBRT to the liver in November 2025.  The metastasis in hepatic segment III has decreased from 1.8 cm to 1.3 cm and is now non-enhancing with improved diffusion restriction — findings consistent with treatment response.  Importantly, there are no new suspicious liver lesions.

Liver Lesion 3-Months Post Radiation

The remainder of the radiology report reads as follows:

• The radiated right pelvic/sacral mass — the original metastasis that once prompted discussion of a semi-hemipelvectomy — remains stable at 6.3 × 3.8 cm.
• Subcentimeter lesions in the left iliac wing and posterior acetabulum are stable since 2024 and smaller compared to 2019.
• The radiated metastasis in the right inferior posteromedial perinephric space (near right kidney) remains stable at 1.7 cm.
• The 1.6 cm enhancing nodule adjacent to the pancreatic head (previously biopsied) remains stable and continues to be favored as a separate process.
• Stable sub-4 mm pulmonary micronodules.
• No new chest, abdomen, or pelvic masses or bone lesions.

For anyone living scan-to-scan, “stable” and “no new lesions” is never a small statement.  That said, this is becoming quite the laundry list to keep track of!

The Bigger Picture

These seven years have not been surveillance. I have been on continuous chemotherapy since January 2019, with targeted radiation to the pelvic/sacral mass, the perinephric lesion (near the kidney), and most recently hepatic segment III.

Ten years NED.
Then metastatic recurrence.
Seven years of active treatment.

Still walking.
Still working.
Still “stable.”

I do not take that word lightly.

Onward.

--Dave